These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 15791290

  • 1. The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.
    Dumoulin MJ, Adam A, Burnett J, Heublein D, Yamaguchi N, Lamontagne D.
    Can J Physiol Pharmacol; 2005 Feb; 83(2):166-73. PubMed ID: 15791290
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
    Wang CH, Leung N, Lapointe N, Szeto L, Uffelman KD, Giacca A, Rouleau JL, Lewis GF.
    Circulation; 2003 Apr 15; 107(14):1923-9. PubMed ID: 12668518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W, Martorana PA, Schölkens BA.
    J Cardiovasc Pharmacol; 1990 Apr 15; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W, Wiemer G, Schölkens BA.
    Diabetes; 1996 Jan 15; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [Abstract] [Full Text] [Related]

  • 8. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM, Belloni AS, Guidolin D, Sticchi D, Nussdorfer GG, Pessina AC, Rossi GP.
    J Hypertens; 2006 Jul 15; 24(7):1419-27. PubMed ID: 16794493
    [Abstract] [Full Text] [Related]

  • 9. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG, Yu C, Renner T, Thibodeaux H, Armstrong SR, Park T, Cheruvu M, Olsufka R, Sandvik ER, Lane CE, Budman J, Hill CM, Klein U, Hegde SS.
    J Cardiovasc Pharmacol; 2011 Apr 15; 57(4):495-504. PubMed ID: 21297495
    [Abstract] [Full Text] [Related]

  • 10. Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression.
    Blais C, Lapointe N, Rouleau JL, Clément R, Bachvarov DR, Adam A.
    Can J Physiol Pharmacol; 2002 Jan 15; 80(1):48-58. PubMed ID: 11911226
    [Abstract] [Full Text] [Related]

  • 11. Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed.
    Dumoulin MJ, Adam A, Rouleau JL, Lamontagne D.
    J Cardiovasc Pharmacol; 2001 Apr 15; 37(4):359-66. PubMed ID: 11300648
    [Abstract] [Full Text] [Related]

  • 12. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC, Pullen MA, Edwards RM, Brooks DP.
    J Pharmacol Exp Ther; 2004 Jun 15; 309(3):1141-7. PubMed ID: 14769834
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H, Miatello R, Damiani MT, Abate CD.
    Immunopharmacology; 1997 Jun 15; 36(2-3):185-91. PubMed ID: 9228545
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA.
    J Clin Invest; 1997 Apr 15; 99(8):1926-35. PubMed ID: 9109437
    [Abstract] [Full Text] [Related]

  • 17. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S, Richardt G, Dominiak P, Katus HA, Dendorfer A.
    Br J Pharmacol; 2001 Sep 15; 134(2):370-4. PubMed ID: 11564655
    [Abstract] [Full Text] [Related]

  • 18. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
    Braun C, Kleemann T, Hilgenfeldt U, Riester U, Rohmeiss P, van der Woude FJ.
    Kidney Int; 2002 Jun 15; 61(6):2149-56. PubMed ID: 12028455
    [Abstract] [Full Text] [Related]

  • 19. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
    Linz W, Wiemer G, Schölkens BA.
    Braz J Med Biol Res; 1994 Aug 15; 27(8):1949-54. PubMed ID: 7749386
    [Abstract] [Full Text] [Related]

  • 20. A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart.
    Lagneux C, Adam A, Lamontagne D.
    Int Immunopharmacol; 2003 Oct 15; 3(10-11):1511-8. PubMed ID: 12946448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.